JNJ

2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
Is Johnson and Johnson Still a Safe Play?
Wall St Cheat Street
Sat, 12/29/12 - 10:28 am
JNJ
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Will FDA Grant Accelerated Approval To J&J TB Drug?
Pharmalot
Fri, 12/28/12 - 11:33 am
FDA
JNJ
tuberculosis
bedaquiline
Pfizer Playing the Right Card Amid Changing Sector Landscape
Motley Fool
Fri, 12/28/12 - 11:31 am
Pfizer
Merck
JNJ
J&J Declines to Comment on U.S. Approval of Sanofi Deal
Bloomberg
Thu, 12/27/12 - 10:09 pm
JNJ
Sanofi
antitrust
The 1 Biotech Event You Can't Miss This Week
Motley Fool
Sun, 12/23/12 - 05:24 pm
JNJ
bedaquiline
tuberculosis
The Worst Could Be Over for J&J
WSJ Online
Sun, 12/23/12 - 10:03 am
JNJ
Why Berkshire Soured on Johnson & Johnson
Motley Fool
Sat, 12/22/12 - 12:36 pm
JNJ
Analyst Roundtable: Big Pharma Spinoffs
Motley Fool
Wed, 12/19/12 - 11:11 am
Abbott Labs
JNJ
[video]Should Johnson & Johnson Split Up?
Motley Fool
Tue, 12/18/12 - 11:13 am
JNJ
China Biotech In Review: China Leads Emerging Countries Pharma M&A
Seeking Alpha
Sun, 12/16/12 - 10:59 am
Sinopharm
Fosun Pharmaceutical
Delmar Pharma
Mauna Kea Technologies
Veridex
JNJ
Not Just a Band-Aid
Barron's
Sat, 12/15/12 - 01:22 pm
JNJ
Big Yields in Drug Land
Motley Fool
Sat, 12/15/12 - 12:53 pm
Pfizer
Merck
JNJ
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
PDL Biopharma
RNA Technology Could Save Lives, Create Investment Opportunity
Motley Fool
Sat, 12/15/12 - 12:33 pm
JNJ
Zytiga
Dendreon
Provenge
Big News for This Blockbuster Drug
Motley Fool
Sat, 12/15/12 - 11:27 am
JNJ
Zytiga
prostate cancer
Dendreon Dodges A Bullet
Seeking Alpha
Tue, 12/11/12 - 10:18 am
JNJ
Dendreon
Zytiga
prostate cancer
Provenge
FDA approves J&J's Zytiga for men who have not yet received chemotherapy for prostate tumors
Yahoo/AP
Tue, 12/11/12 - 08:17 am
FDA
JNJ
Zytiga
prostate cancer
Major Weekend Biotech Announcements Could Produce Gains on Monday
Motley Fool
Mon, 12/10/12 - 10:39 am
Pharmacyclics
JNJ
ibrutinib
Eliquis
Pfizer
Bristol-Myers Squibb
This Week in Biotech
Motley Fool
Sun, 12/9/12 - 11:23 am
JNJ
Chelsea Therapeutics
Anika
Geron
Zogenix

Pages